Arthritis Prevention in the Pre-Clinical Phase of RA With Abatacept (The APIPPRA Study): A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial Protocol

Trials - United Kingdom
doi 10.1186/s13063-019-3403-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

CONFIRM: A Double-Blind, Placebo-Controlled Phase III Clinical Trial Investigating the Effect of Nivolumab in Patients With Relapsed Mesothelioma: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2018English

TRYMS: The Ethical and Practical Considerations of a Double-Blind Placebo Controlled Randomised Clinical Trial

Trials
MedicinePharmacology
2015English

Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2016English

A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Limited Effect of Sulphasalazine Treatment in Reactive Arthritis. A Randomised Double Blind Placebo Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1997English

Antioxidant Supplementation for the Prevention of Kwashiorkor in Malawian Children: Randomised, Double Blind, Placebo Controlled Trial

BMJ
2005English

Randomised, Double Blind, Placebo Controlled Clinical Trial of Efficacy of Vitamin a Treatment in Non-Measles Childhood Pneumonia

BMJ
1997English

Study Protocol for a Randomised, Double-Blind, Placebo-Controlled Clinical Trial of Duloxetine for the Treatment and Prevention of Musculoskeletal Pain: Altering the Transition From Acute to Chronic Pain (ATTAC Pain)

BMJ Open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy